Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ductal Carcinoma in Situ of the Breast”

308 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 308 results

Not applicableWithdrawnNCT01729832
What this trial is testing

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituRecurrent Breast Cancer+7 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06868238
What this trial is testing

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Who this might be right for
Ductal Carcinoma in Situ
University of Florida 30
Not applicableActive Not RecruitingNCT02889458
What this trial is testing

Hong Kong Breast Cancer Study

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
The University of Hong Kong 7,000
Testing effectiveness (Phase 2)WithdrawnNCT02336984
What this trial is testing

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Not applicableStudy completedNCT03664778
What this trial is testing

Abbreviated Breast MRI After Cancer Treatment

Who this might be right for
Breast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
University of Pennsylvania 184
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Study completedNCT00072462
What this trial is testing

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Queen Mary University of London 2,980
Not applicableActive Not RecruitingNCT04225585
What this trial is testing

Well-Being After Breast Cancer Surgery

Who this might be right for
Coping Skills Training for Persistent Post-Surgical PainGeneral Health Education
Duke University 316
Not applicableStudy completedNCT03834532
What this trial is testing

Living Well After Breast Surgery

Who this might be right for
Breast Cancer FemaleStage I Breast CancerStage II Breast Cancer+4 more
University of Texas at Austin 17
Not applicableUnknownNCT00126464
What this trial is testing

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 100
Not applicableStudy completedNCT00390962
What this trial is testing

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Who this might be right for
StrokeTransient Ischemic Attack
University Hospital, Basel, Switzerland 469
Testing effectiveness (Phase 2)Study completedNCT00290745
What this trial is testing

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, San Francisco 79
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Testing effectiveness (Phase 2)Study completedNCT01439711
What this trial is testing

Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 108
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Active Not RecruitingNCT05900986
What this trial is testing

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Who this might be right for
Breast CancerDCISInvasive Duct Carcinoma of Breast
Integro Theranostics 100
Large-scale testing (Phase 3)UnknownNCT00402519
What this trial is testing

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Who this might be right for
Breast Cancer
University of Erlangen-Nürnberg Medical School 1,300
Not applicableStudy completedNCT04498611
What this trial is testing

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

Who this might be right for
Carcinoma, Ductal, BreastInvasive Breast CancerIMAGE
Seoul National University Hospital 113
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960
Load More Results